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BACKGROUND: Intracerebral haemorrhage (ICH) is the most disabling and least treatable form of
stroke. Its risk factors include old age, hypertension, diabetes mellitus, hypercholesterolaemia, smoking
and high alcohol intake, which are also associated with arterial stiffness. The aim of the present study
was to determine the prognostic value of high augmentation index (AI), which is a surrogate marker of
arterial stiffness, in patients with spontaneous ICH.
METHODS: A prospective study of 60 patients with spontaneous supratentorial ICH was conducted.
Outcome was assessed using the Modified Rankin Scale at 3 months follow-up. Data were collected on
age and sex, risk factors for ICH, clinical parameters, laboratory parameters, radiological findings and
hospital management. Logistic regression analysis was carried out to identify independent predictors of
3-month outcome and mortality.
RESULTS: Admission Glasgow Coma Scale score (OR, 0.7; 95% CI, 0.450–0.971; p = 0.035), total leukocyte
count (OR,1.2; 95% CI, 1.028–1.453; p = 0.023) and haematoma volume (OR, 1.1; 95% CI, 1.024–1.204;
p = 0.011) were found to be statistically significant in multivariate analysis of 3-month poor outcome.
Factors independently associated with mortality were high AI (OR, 8.6; 95%CI, 1.748–40.940; 
p = 0.007) and midline shift (OR, 7.5; 95%CI, 1.809–31.004; p = 0.005).
CONCLUSION: Admission Glasgow Coma Scale score, total leukocyte count and haematoma volume
were significant predictors for 3-month poor outcome; high AI and midline shift were significant predictors
for 3-month mortality. [Asian J Surg 2010;33(1):42–50]
Key Words: augmentation index, Glasgow Coma Scale, intracerebral haemorrhage, mortality, prognosis,
triglyceride
Introduction
Intracerebral haemorrhage (ICH) accounts for 15–30% of
all strokes and has an estimated incidence of 37,000 cases
per year  in the United States.1 Despite improvement in
neurointensive care, the morbidity and mortality of ICH
remain high. The 6-month morbidity and mortality of
ICH is 30–50% and only 20% regain functional independence
at 6 months.2 Although ICH risk factors such as ageing,
hypertension, diabetes mellitus and hypercholesterolaemia
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are closely associated with arterial stiffness, the predictive
value of the augmentation index (AI), which is a surrogate
marker of arterial stiffness, remains unknown.
The aim of the present study was to analyse whether
high AI was associated with 3-month poor outcome
[Modified Rankin Scale (MRS) 5 and 6] or 3-month mor-
tality of ICH. Various clinical, biochemical, haematologi-
cal, radiological and treatment factors were also included
in the study to assess their predictive value for 3-month
outcome and mortality of ICH.
Patients and methods
Patients
This prospective study was conducted at Hospital
Universiti Sains Malaysia from May 2006 to May 2008. All
patients with spontaneous ICH who fulfilled the inclu-
sion and exclusion criteria were enrolled. Patients aged
18–85 years were eligible for inclusion if consent was
obtained from their relatives, and they had evidence of
spontaneous supratentorial ICH on initial brain com-
puted tomography (CT). Patients were excluded if there
was clear evidence that the haemorrhage was due to an
aneurysm, arteriovenous malformation, trauma, tumour
or coagulopathy. Other exclusion criteria included a history
of severe heart disease, stroke, end-stage renal failure or
severe systemic diseases (e.g. cancer or chronic lung dis-
ease), which could interfere with outcome assessment,
and severe pre-existing physical or mental disability.
Clinical and laboratory analysis
The diagnosis of spontaneous supratentorial ICH was
based on a history of typical acute clinical onset and con-
firmed by brain CT scan. Spontaneous intracerebral
haematoma referred to those occurring without any asso-
ciated history of trauma, coagulopathy or surgery. Demo-
graphic data including age and sex were collected. Risk
factors for ICH including hypertension, diabetes mellitus,
smoking status and hypercholesterolaemia were recorded.
Glasgow Coma Scale (GCS) score in the emergency depart-
ment was recorded. Body height and weight, body mass
index (BMI), systolic blood pressure, diastolic blood pres-
sure, mean arterial pressure, heart rate, right carotid
blood flow (CBF), left CBF, and AI were measured and
recorded on admission. The bilateral internal CBF was
measured using DWL Embo-Dop Doppler machine
(Compumedics Germany GmbH, Sipplingen, Germany)
with a 2-MHz probe. AI was defined as the proportion of
central pulse pressure that was caused by late systolic
peak, which was in turn attributed to the reflected pulse
wave. The SphygmoCor system (AtCor Medical, Sydney,
Australia) was used to record radial artery pressure wave-
form data by a small handheld tonometer. The acquired
data were used to calculate central pressure through a
generalized mathematical transfer function. Those with
values higher than the normal range were labelled with a
high AI, which was suggestive of arterial stiffness. Blood
was taken on admission for haematological and biochem-
ical tests, including: total leukocyte count (TLC); haemo-
globin level; platelet count; random blood sugar; serum
sodium, potassium, urea, creatinine, total cholesterol,
low-density lipoprotein, high-density lipoprotein and
triglyceride; international normalized ratio; and activated
partial thromboplastin time. Cardiothoracic ratio was
measured from chest radiography to rule out cardiomegaly
(ratio > 0.5). CT findings, such as side, site and volume of
haematoma, and evidence of MLS, ventricular extension
and hydrocephalus, were recorded. Supratentorial intracra-
nial haematoma can be classified into lobar (frontal, pari-
etal, temporal or occipital) or ganglionic (basal ganglia or
thalamic). Intracranial haematoma volume was measured
using the ABC/2 method,3 in which A was the greatest
diameter on the largest haematoma slice, B was the diam-
eter perpendicular to A, and C was the appropriate num-
ber of axial slices with haematoma multiplied by the slice
thickness.
Treatment and follow-up
Subsequently, all patients were treated according to the
standard treatment protocol of our hospital. The indica-
tions for surgical evacuation of ICH in our hospital were
significant haematoma with a volume >30 mL, haematoma
within 1 cm of the cortex, and GCS score of 8–12. External
ventricular drainage was indicated in patients with signif-
icant hydrocephalus secondary to ICH with ventricular
extension. In-hospital treatment (conservative therapy or
surgical intervention) and type of surgical procedure (cran-
iotomy or external ventricular drainage) were recorded.
Patients were followed up for a maximum period of 
3 months from the onset of stroke. Patients discharged
from hospital before this period were asked to visit our
neurosurgery outpatient clinic. For those who failed to
turn up for follow-up, outcome was ascertained through
telephone interview. The outcome measure was the MRS
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score at 3 months. The 3-month outcome was divided
into two groups: good outcome (MRS score 0–4) and
poor outcome (MRS score 5 and 6). The MRS score ranges
from 0 to 6 (0, no symptoms; 1, no significant disability
despite symptoms, and able to carry out all usual duties
and activities; 2, slight disability and able to look after
own affairs without assistance, but unable to carry out all
previous activities; 3, moderate disability, requiring some
help, but able to walk without assistance; 4, moderately
severe disability, and unable to walk and attend to own
bodily needs without assistance; 5, severe disability,
bedridden, incontinent and requiring constant nursing
care and attention; 6, death).4
Statistical analysis
Data entry and analysis were done using SPSS version
12.0 (SPSS Inc., Chicago, IL, USA). For descriptive anal-
ysis, continuous variables were described using the
mean ± standard deviation (SD), whereas categorical vari-
ables were described as frequency and percentage. For uni-
variate analysis, the χ2 and Fisher exact tests were used 
to analyse categorical variables, as appropriate, and the
Student t test was used to analyse continuous variables. 
A p < 0.05 was considered statistically significant for uni-
variate analysis. Significant variables in univariate analy-
sis were included in multivariate analysis. In multivariate
analysis, multiple logistic regression with forward, back-
ward likelihood ratio and manual elimination methods
was used to derive the final model. The final model was
examined for fitness by using the Hosmer–Lemeshow
goodness-of-fit test. All results were expressed as odd
ratio (OR) and 95% confidence interval (CI).
Results
Sixty patients with spontaneous ICH were recruited, and
their demographic characteristics are summarized in
Table 1. Twenty-four patients (40%) had a good outcome and
36 (60%) had a poor outcome at 3 months. Thirty-eight
patients (63.3%) were still alive but 22 (36.7%) had died at
3 months. Twelve of the 36 poor outcome patients
(33.3%) had a high AI and 24 (66.7%) had a normal AI. In
the 3-month mortality group, 10 of 22 patients (45.5%) had
a high AI. The univariate analysis (Tables 2 and 3) revealed
that GCS score (p = 0.003), TLC (p = 0.048), site of
haematoma (p = 0.009), volume of haematoma (p = 0.021),
MLS (p < 0.001) and hydrocephalus (p = 0.007) were asso-
ciated with poor outcome at 3 months. Parameters asso-
ciated with 3-month mortality in univariate analysis were 
diabetes mellitus (p = 0.030), heart rate (p = 0.050), right
CBF (p = 0.023), high AI (p = 0.005), random blood sugar
(p = 0.029), serum urea (p = 0.004), serum creatinine 
(p = 0.001), MLS (p = 0.003) and hydrocephalus (p = 0.006)
(Tables 4 and 5). Multivariate analysis showed GCS score,
TLC and volume of haematoma were associated with 
3-month poor outcome, and high AI and MLS were fac-
tors associated with 3-month mortality. The final model
of the variables that predicted 3-month outcome and
mortality is shown in Tables 6 and 7.
Discussion
This prospective study showed that high AI (OR: 8.6; 95%
CI: 1.748–40.940; p = 0.007) was a significant predictor for
3-month mortality in patients with ICH. Patient with
high AI had an 8.6-fold greater risk of mortality. This is
believed to be the first study to assess the association
between high AI and ICH outcome and mortality. AI is a
surrogate marker for arterial stiffness and has been
shown to be useful in predicting cardiovascular events in
end-stage renal failure,5 coronary artery disease6 and
patients undergoing percutaneous coronary interven-
tion.7 AI also has predictive value for target organ failure.
High AI is associated with left ventricular hypertrophy in
normotensive subjects,8 haemodialysis patients,9 and
patients with essential hypertension.10 In addition, high
AI is also associated with diabetic retinopathy11 and uri-
nary albumin excretion.12
Old age is an important factor linked to poor prog-
nosis in ICH.13–15 A recent study by Smajlovic et al16 on
30-day prognosis in 352 patients with ICH has concluded
that age is an independent predictor for 30-day mortality.
Our study showed no significant association between 
age and outcome, but this was probably due to the small
sample size.
Table 1. Demographic profile of patients (n = 60)
Age (yr) 56.7 ± 10.46
Sex (male/female) 36/24
Hypertension 57 (95%)
Diabetes mellitus 18 (30%)
Current smoker 20 (33.3%)
Hypercholesterolaemia 23 (38.3%)
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Table 2. Univariate analysis of various demographic, clinical, laboratory, radiographic and treatment parameters in relation to 
3-month outcome for continuous variables
Continuous variables 
Good outcome (n = 24) Bad outcome (n = 36) 
p
M ± SD M ± SD
Age (yr) 54.7 ± 12.8 58.1 ± 8.5 0.083
Height (m) 1.60 ± 0.07 1.60 ± 0.09 0.150
Weight (kg) 71.1 ± 10.0 68.9 ± 11.4 0.570
BMI (kg/m2) 27.9 ± 4.2 26.8 ± 3.3 0.103
SBP (mmHg) 191.5 ± 27.8 199.9 ± 26.0 0.731
DBP (mmHg) 108.9 ± 16.7 112.4 ± 14.0 0.413
MAP (mmHg) 136.4 ± 19.0 141.6 ± 16.1 0.638
Heart rate (beats/min) 78.6 ± 15.6 82.8 ± 17.7 0.443
Augmentation index 24.2 ± 10.6 28.3 ± 11.3 0.575
Right CBF (cm/sec) 16.8 ± 4.9 18.6 ± 5.9 0.389
Left CBF (cm/sec) 16.8 ± 5.9 17.8 ± 6.5 0.446
GCS 13.7 ± 1.9 9.9 ± 3.2 0.003
TLC (×109/L) 11.3 ± 3.0 13.1 ± 6.5 0.048
Haemoglobin (g/L) 140 ± 16 135 ± 23 0.355
Platelets (×109/L) 235.3 ± 54.7 266.8 ± 71.7 0.207
Random blood sugar (mmol/L) 7.50 ± 2.96 7.76 ± 3.34 0.735
Sodium (mmol/L) 136.6 ± 4.8 136.9 ± 4.2 0.476
Potassium (mmol/L) 3.34 ± 0.47 3.44 ± 0.53 0.394
Urea (mmol/L) 6.06 ± 1.88 6.71 ± 3.96 0.054
Creatinine (mmol/L) 117.8 ± 40.6 144.7 ± 121.8 0.103
INR 1.06 ± 0.10 1.05 ± 0.10 0.788
APTT (sec) 30.2 ± 4.8 30.9 ± 7.5 0.052
LDL (mmol/L) 3.57 ± 1.27 3.92 ± 1.47 0.503
Triglyceride (mmol/L) 1.20 ± 0.55 1.41 ± 0.79 0.501
Total cholesterol (mmol/L) 5.41 ± 1.49 5.87 ± 1.68 0.755
HDL (mmol/L) 1.27 ± 0.30 1.31 ± 0.38 0.239
Volume of haematoma (mL) 9.30 ± 11.35 28.29 ± 19.22 0.021
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; CBF = carotid blood
flow; GCS = Glasgow Coma Scale; TLC = total leukocyte count; INR = international normalised ratio; APTT = activated partial thromboplastin
time; LDL = low-density lipoprotein; HDL = high-density lipoprotein.
Upon analysis of the risk factors for ICH in the present
study (hypertension, diabetes mellitus, current smoking,
and hypercholesterolaemia), none had any association
with ICH outcome and mortality. The association
between the risk factors for ICH and its outcome is still
inconclusive. Smajlovic et al16 have reported that hyper-
tension, diabetes mellitus and smoking are not associated
with ICH outcome and mortality. Togha and Bakhtavar17
and Passero et al18 have shown that diabetes mellitus is
associated with poor outcome and mortality in ICH.
With regard to the various clinical parameters in this
study, GCS score was a significant predictor of 3-month
outcome of ICH. Patients with a high GCS score had 0.7
times less chance of being associated with poor outcome.
These findings are in accordance with many other studies
in which GCS score was the most important and consis-
tent predictor of ICH outcome and mortality.17,19–23
A few studies have shown that high blood pressure on
admission is associated with poor outcome of ICH. In 
a study of 221 patients, Ahmed et al24 have shown that 
systolic blood pressure ≥ 180 mmHg was a predictor of
ICH mortality. In a study of 1,701 patients, Terayama 
et al25 have reported that increased mean arterial pressure
was associated with increased mortality. However, blood
pressure on admission in the present study did not affect
the outcome and mortality of ICH.
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Table 3. Univariate analysis of various demographic, clinical, laboratory, radiographic and treatment parameters in relation to 
3-month outcome for categorical variables
Categorical variables Good outcome n (%) Poor outcome n (%) p OR (95% CI)
Sex 0.747* 1.190
Male 15 (41.7) 21 (58.3) (0.413–3.433)
Female 9 (37.5) 15 (62.5)
Hypertension 0.558† 3.182
Yes 22 (38.6) 35 (61.4) (0.272–37.204)
No 2 (66.7) 1 (33.3)
Diabetes mellitus 0.543* 1.462
Yes 5 (33.3) 10 (66.7) (0.429–4.979)
No 19 (42.2) 26 (57.8)
Smoking 0.576* 1.373
Yes 7 (35.0) 13 (65.0) (0.451–4.175)
No 17 (42.5) 23 (57.5)
Hypercholesterolaemia 0.515* 1.429
Yes 8 (34.8) 15 (65.2) (0.487–4.193)
No 16 (43.2) 21 (56.8)
High augmentation index 0.068* 3.500
Yes 3 (20.0) 12 (80.0) (0.868–14.110)
No 21 (46.7) 24 (53.3)
Cardiomegaly 0.490* 0.667
Yes 18 (42.9) 24 (57.1) (0.210–2.116)
No 6 (33.3) 12 (66.7)
Site of haematoma 0.009* 0.086
Lobar 6 (85.7) 1 (14.3) (0.010–0.767)
Ganglionic 18 (34.0) 35 (66.0)
Side of haematoma 0.342* 0.604
Right 11 (33.3) 21 (66.7) (0.213–1.712)
Left 13 (46.4) 15 (53.6)
MLS < 0.001* 12.294
Yes 2 (9.5) 19 (90.5) (2.511–60.2)
No 22 (56.4) 17 (43.6)
Ventricular extension 0.340* 1.667
Yes 9 (33.3) 18 (66.7) (0.581–4.779)
No 15 (45.5) 18 (54.5)
Hydrocephalus 0.007* 11.5
Yes 1 (7.7) 12 (92.3) (1.382–95.678)
No 23 (48.9) 24 (51.1)
Treatment 0.352* 2.200
Conservative 22 (42.3) 30 (57.7) (0.405–33.943)
Surgery 2 (25) 6 (75)
EVD 0.387† 3.710
Yes 1 (16.7) 5 (23.3) (0.405–33.943)
No 23 (42.6) 31 (57.4)
Craniotomy > 0.95† 0.657
Yes 1 (50.0) 1 (50.0) (0.039–11.039)
No 23 (39.7) 35 (60.3)
*χ2 test; †Fisher’s exact test. MLS = midline shift; EVD = external ventricular drainage.
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Table 4. Univariate analysis of various demographic, clinical, laboratory, radiographic and treatment parameters in relation to 
3-month mortality for continuous variables
Continuous variables 
Survived (n = 38) Fatal (n = 22)
p
M ± SD M ± SD
Age (yr) 55.4 ± 10.8 59.0 ± 9.6 0.830
Height (m) 1.60 ± 0.07 1.60 ± 0.09 0.081
Weight (kg) 70.1 ± 9.9 68.2 ± 12.4 0.124
BMI (kg/m2) 27.7 ± 3.9 26.4 ± 3.2 0.369
SBP (mmHg) 193.2 ± 25.9 202.3 ± 28.0 0.427
DBP (mmHg) 112.0 ± 15.5 109.1 ± 14.5 0.749
MAP (mmHg) 139.1 ± 17.4 140.3 ± 17.7 0.549
Heart rate (beats/min) 81.6 ± 18.4 80.4 ± 14.2 0.050
Augmentation index 25.0 ± 10.1 29.6 ± 12.3 0.438
Right CBF (cm/sec) 17.3 ± 4.5 18.9 ± 7.0 0.023
Left CBF (cm/sec) 17.0 ± 5.2 18.2 ± 7.9 0.943
GCS 13.0 ± 2.4 8.7 ± 3.1 0.260
TLC (×109/L) 11.1 ± 3.6 14.5 ± 7.1 0.162
Haemoglobin (g/L) 138 ± 20 135 ± 21 0.507
Platelets (×109/L) 245.8 ± 60.3 268.7 ± 75.9 0.103
Random blood sugar (mmol/L) 7.08 ± 2.46 8.66 ± 3.99 0.029
Sodium (mmol/L) 136.9 ± 4.8 136.6 ± 3.9 0.455
Potassium (mmol/L) 3.32 ± 0.48 3.52 ± 0.54 0.362
Urea (mmol/L) 6.17 ± 1.99 6.93 ± 4.79 0.004
Creatinine (mmol/L) 116.5 ± 38.9 164.2±151.2 0.001
INR 1.06 ± 0.10 1.05 ± 0.11 0.644
APTT (sec) 31.2 ± 6.2 29.6 ± 7.0 0.402
LDL (mmol/L) 3.70 ± 1.31 3.92 ± 1.55 0.692
Triglyceride (mmol/L) 1.17 ± 0.51 1.60 ± 0.90 0.053
Total cholesterol (mmol/L) 5.48 ± 1.49 6.03 ± 1.78 0.858
HDL (mmol/L) 1.25 ± 0.31 1.35 ± 0.40 0.377
Volume of haematoma (mL) 14.6 ± 17.5 31.2 ± 16.7 0.924
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; CBF = carotid blood
flow; GCS = Glasgow Coma Scale; TLC = total leukocyte count; INR = international normalised ratio; APTT = activated partial thromboplastin
time; LDL = low-density lipoprotein; HDL = high-density lipoprotein.
With regard to various haematological and biochem-
ical parameters, only TLC was a significant predictor of 
3-month poor outcome of ICH (OR: 1.2; 95% CI: 1.028–
1.453; p = 0.023). High TLC increased the risk of poor out-
come by a factor of 1.2. Leukocytosis in ICH was a stress-
induced reaction of leukocyte count.26 High TLC is an
independent predictor of mortality in ICH.22,27 A prospec-
tive study by Czlonkowska et al28 has reported that
haematocrit and TLC were predictors for 30-day mortal-
ity in 345 stroke patients. Total cholesterol and triglyc-
eride levels were not associated with ICH outcome and
mortality in our study. Roquer et al29 have reported that
low serum cholesterol and triglyceride levels during 
the first 48 hours after ICH were strong independent 
predictors of in-hospital mortality in 184 patients with
spontaneous supratentorial ICH. Hyperglycaemia on
admission is associated with poor outcome and mortal-
ity.30–32 In our study, the haemoglobin and platelet levels
were not associated with ICH outcome and mortality.
Radiological factors have important prognostic value
in ICH patients. Haematoma volume (OR: 1.1; 95% CI:
1.024–1.204; p = 0.011) was a significant predictor of 
3-month poor outcome, whereas MLS (OR: 7.5; 95% CI:
1.809–31.004; p = 0.005) was a significant predictor of ICH
3-month mortality. Intracranial haematoma with evidence
of MLS was associated with a 7.5-fold risk of mortality.
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Table 5. Univariate analysis of various demographic, clinical, laboratory, radiographic and treatment parameters in relation to 
3-month mortality for categorical variables
Categorical variables Good outcome n (%) Poor outcome n (%) p OR (95% CI)
Sex 0.662* 0.786
Male 22 (61.1) 14 (38.9) (0.266–2.317)
Female 16 (66.7) 8 (33.3)
Hypertension 1.000† 1.167
Yes 36 (63.2) 21 (36.8) (0.100–13.656)
No 2 (66.7) 1 (33.3)
Diabetes mellitus 0.030* 3.692
Yes 6 (40) 9 (60) (1.093–12.477)
No 32 (71.1) 13 (28.9)
Smoking 0.705* 1.238
Yes 12 (60) 8 (40) (0.410–3.740)
No 26 (65) 14 (35)
Hypercholesterolaemia 0.388* 1.603
Yes 13 (56.5) 10 (43.5) (0.548–4.691)
No 25 (67.6) 12 (32.4)
High augmentation index 0.005* 5.500
Yes 5 (33.3) 10 (66.7) (1.559–19.400)
No 33 (73.3) 12 (26.7)
Cardiomegaly 0.047* 0.320
Yes 30 (71.4) 12 (28.6) (0.102–1.006)
No 8 (44.4) 10 (55.6)
Site of haematoma 0.191* 0.254
Lobar 6 (85.7) 1 (14.3) (0.028–2.263)
Ganglionic 32 (60.4) 21 (39.6)
Side of haematoma 0.694* 1.235
Right 21 (63.6) 11 (36.4) (0.431–3.538)
Left 17 (60.7) 11 (39.3)
MLS 0.003* 5.417
Yes 8 (38.1) 13 (61.9) (1.709–17.167)
No 30 (76.9) 9 (23.1)
Ventricular extension 0.095* 2.476
Yes 14 (51.9) 13 (48.1) (0.845–7.259)
No 24 (72.7) 9 (27.3)
Hydrocephalus 0.006* 5.885
Yes 4 (30.8) 9 (69.2) (1.541–22.474)
No 34 (72.3) 13 (27.7)
Treatment 0.958* 1.042
Conservative 33 (63.5) 19 (36.5) (0.224–4.854)
Surgery 5 (62.5) 3 (37.5)
EVD 0.659† 1.842
Yes 3 (50) 3 (50) (0.338–10.033)
No 35 (64.8) 19 (35.2)
Craniotomy 0.528† 0
Yes 2 (100) 0 (0)
No 36 (62.1) 22 (37.9)
*χ2 test; †Fisher’s exact test. OR = odds ratio; CI = confidence interval; MLS = midline shift; EVD = external ventricular drainage.
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Table 6. Final model with significant variables predicting 3-month poor outcome*
Variable B SE Wald OR (95% CI) p
GCS −0.414 0.196 4.458 0.7 (0.450–0.971) 0.035
TLC 0.200 0.088 5.149 1.2 (1.028–1.453) 0.023
Volume of haematoma 0.105 0.041 6.395 1.1 (1.024–1.204) 0.011
*Adjusted for GCS, TLC, site of haematoma, volume of haematoma, midline shift, hydrocephalus. Constant = 1.881, Hosmer–Lemeshow test
p = 0.188, overall percentage correct = 85%. GCS = Glasgow Coma Scale; TLC = total leukocyte count; OR = odds ratio; CI = confidence interval.
Haematoma volume is an established outcome predictor
for ICH patients.17,21,33–35 Delgado et al34 have shown that
haematoma volume > 30 mL was an independent predic-
tor for mortality in 98 ICH patients. Associated intraven-
tricular haemorrhage and hydrocephalus are important
predictors of poor outcome in ICH.36 In our study, these
factors did not significantly affect ICH outcome and mor-
tality, which could have been due to the small sample size.
Type of inpatient treatment (conservative or surgical)
and surgery (external ventricular drainage or craniotomy)
was not associated with outcome and mortality in the
present study, although this could also have been due to
the small sample size.
Conclusions
This prospective study of 60 ICH patients showed a 
3-month mortality of 36.7%, and 60% had a poor 3-month
outcome. GCS score, TLC and volume of haematoma
were independent predictors of 3-month outcome in 
multivariate analysis. The significant predictors for 
3-month mortality in ICH were high AI and MLS.
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